Log In
BCIQ
Print this Print this
 

GLA-SE (G100) (formerly GL-100, ID-G100)

  Manage Alerts
Collapse Summary General Information
Company Immune Design Corp.
DescriptionToll-like receptor 4 (TLR4) agonist
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionImmunotherapy; Toll-like receptor 4 (TLR4) agonist
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/10/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today